Serum GFAP versus NfL for predicting disability progression in multiple sclerosis: A systematic review and meta-analysis

Authors
Category Systematic review
Conference12th Congress of the European Academy of Neurology
Year 2026
This article has no abstract
Epistemonikos ID: 222a140f903f9ccc024caac63901b804bedd3793
First added on: Sep 09, 2026